Wealth Alliance »

Heron Therapeutics shares owned by Wealth Alliance

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by Wealth Alliance from 13F filings

Historical chart of Wealth Alliance investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by Wealth Alliance consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by Wealth Alliance

Quarter filed Position value Share count Share price at filing
2023-12-31 $34k 20k 1.70
2023-09-30 $21k 20k 1.03

More positions owned by Wealth Alliance

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Ishares Tr Core Total Usd (IUSB)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr Eafe Value Etf (EFV)
Amazon (AMZN)
Ishares Tr Esg Awr Msci Usa (ESGU)
Ishares Tr S&p 500 Grwt Etf (IVW)
Alps Etf Tr Alerian Mlp (AMLP)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr S&p 500 Val Etf (IVE)
Ishares Tr S&p 100 Etf (OEF)
Ishares Tr Eafe Grwth Etf (EFG)
Vanguard Index Fds Real Estate Etf (VNQ)

View all positions for Wealth Alliance

Top funds holding Heron Therapeutics

Vanguard Group
Franklin Resources
Clearline Capital
OrbiMed Advisors
Tejara Capital
Palisade Capital Management
JW Asset Management
Orchard Capital Managment
Monaco Asset Management SAM
Tang Capital Management
Congress Park Capital
D. E. Shaw & Co
Millennium Management
New York State Common Retirement Fund
Charles Schwab Investment Management

View all funds holding Heron Therapeutics